JP2002003362A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2002003362A JP2002003362A JP2000229995A JP2000229995A JP2002003362A JP 2002003362 A JP2002003362 A JP 2002003362A JP 2000229995 A JP2000229995 A JP 2000229995A JP 2000229995 A JP2000229995 A JP 2000229995A JP 2002003362 A JP2002003362 A JP 2002003362A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- rice
- acid
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 44
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 43
- 235000009566 rice Nutrition 0.000 claims abstract description 43
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 13
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 9
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 8
- 241000218922 Magnoliophyta Species 0.000 claims description 20
- 241001123263 Zostera Species 0.000 claims description 14
- 150000000996 L-ascorbic acids Chemical class 0.000 claims description 7
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 4
- 235000019833 protease Nutrition 0.000 claims description 3
- 108010004032 Bromelains Proteins 0.000 claims description 2
- 235000019835 bromelain Nutrition 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 3
- 239000002211 L-ascorbic acid Substances 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 13
- 208000024891 symptom Diseases 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 35
- -1 L-ascorbic acid-2-phosphate ester salt Chemical class 0.000 description 30
- 239000000243 solution Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000006210 lotion Substances 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000000419 plant extract Substances 0.000 description 12
- 208000012641 Pigmentation disease Diseases 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 206010040844 Skin exfoliation Diseases 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000019612 pigmentation Effects 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000004299 exfoliation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 230000037380 skin damage Effects 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 206010042496 Sunburn Diseases 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 241000257465 Echinoidea Species 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- HRBSSAKLPZCBPP-LICCNWEZSA-N (2r)-3,4-dihydroxy-2-[(1s)-2-hydroxy-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2h-furan-5-one Chemical compound O([C@@H](CO)[C@@H]1C(=C(O)C(=O)O1)O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HRBSSAKLPZCBPP-LICCNWEZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HWLBIEAKJSRKOD-UHFFFAOYSA-N 2-octadecanoyloxyacetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)=O HWLBIEAKJSRKOD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101000783705 Myxoma virus (strain Uriarra) Envelope protein A28 homolog Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000021662 Ophichthus gomesii Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000481 effect on pigmentation Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- LRUISGPJGHTCRR-LEJBHHMKSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1O LRUISGPJGHTCRR-LEJBHHMKSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、すぐれた肌荒れ改
善作用と皮膚老化防止作用、そして美白作用を併せ持
ち、紫外線等に基づく皮膚のダメージに対して、その予
防のみならず、特にすぐれた回復効果を発揮し得る皮膚
外用剤に関する。BACKGROUND OF THE INVENTION The present invention has an excellent effect of improving skin roughness, an effect of preventing skin aging, and a lightening effect, and not only prevents skin damage due to ultraviolet rays and the like, but also has a particularly excellent recovery effect. And a skin external preparation capable of exhibiting
【0002】[0002]
【従来の技術】紫外線暴露或いは加齢に伴って生ずる色
素沈着、特にシミ・ソバカスの予防、症状改善を目的と
して、従来よりコウジ酸、アスコルビン酸誘導体、ハイ
ドロキノン誘導体など種々の美白剤が提案され、これら
を配合した皮膚外用剤が上市されている。しかしなが
ら、紫外線による影響は色素沈着だけではなく皮膚の組
織にも悪影響を及ぼし、肌荒れや落屑を起こす。また長
期的には、いわゆる光老化と呼ばれるしわ、たるみの発
生につながっていく。このような紫外線の影響から皮膚
を守り、色素沈着を予防し或いは症状を改善するのみな
らず、皮膚全体の健全化、健常化に寄与するものが求め
られているが、かかる要求に対して従来の美白剤では対
応が困難である。2. Description of the Related Art Various whitening agents such as kojic acid, ascorbic acid derivatives and hydroquinone derivatives have been proposed for the purpose of preventing and improving the symptoms of pigmentation, especially spots and freckles caused by aging or exposure to ultraviolet rays. Skin external preparations containing these are commercially available. However, the effects of ultraviolet rays not only have an adverse effect on pigmentation but also on skin tissue, causing rough skin and desquamation. In the long term, it leads to the generation of wrinkles and so-called sagging called photoaging. Protecting the skin from the effects of such ultraviolet rays, preventing pigmentation or improving symptoms, as well as those that contribute to the overall soundness and health of the skin are required. It is difficult to cope with the whitening agent.
【0003】[0003]
【発明が解決しようとする課題】本発明は、上記の如き
従来技術の問題点に鑑みてなされたものであり、その目
的とするところは、紫外線等に基づく皮膚のダメージに
対して、その防御のみならず、特にすぐれた症状改善効
果を発揮し、皮膚を速やかに健全,健常な状態に回復せ
しめ得る皮膚外用剤を提供することにある。SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned problems of the prior art, and has as its object to protect against skin damage due to ultraviolet rays and the like. In addition, it is an object of the present invention to provide an external preparation for skin which exhibits a particularly excellent symptom ameliorating effect and can promptly restore skin to a healthy and healthy state.
【0004】[0004]
【課題を解決するための手段】即ち、本発明は、米抽出
物の加水分解物と海産顕花植物の抽出物とアスコルビン
酸及び/又はその誘導体とを配合してなる皮膚外用剤で
ある。That is, the present invention is an external preparation for skin comprising a hydrolyzate of a rice extract, an extract of a marine flowering plant, and ascorbic acid and / or a derivative thereof.
【0005】上記の成分構成からなる本発明の皮膚外用
剤を、紫外線に曝された皮膚に適用した場合、それら各
成分の相乗作用によって、顕著な肌荒れ改善効果が発揮
され、皮膚は速やかに健全,健常な状態に回復すると共
に、色素沈着の予防及び症状改善効果も併せ奏せられ、
皮膚に総合的な美粧効果が付与される。[0005] When the skin external preparation of the present invention having the above-mentioned composition is applied to skin exposed to ultraviolet rays, a synergistic action of these components exerts a remarkable effect of improving rough skin, and the skin is promptly healthy. , While restoring to a healthy state, it also has the effect of preventing pigmentation and improving symptoms
A comprehensive cosmetic effect is imparted to the skin.
【0006】以下、本発明について詳細に説明する。本
発明で用いる米抽出物の加水分解物は、米を水、アルコ
ールなどの溶媒で抽出して得られる抽出物を、酸,アル
カリ,酵素などで加水分解してなるものである。Hereinafter, the present invention will be described in detail. The hydrolyzate of the rice extract used in the present invention is obtained by hydrolyzing an extract obtained by extracting rice with a solvent such as water or alcohol with an acid, alkali, enzyme or the like.
【0007】ここで用いる米には特に制限はなく、玄
米、精白米、加工米などのいずれもが使用可能である
が、好適には精白米もしくは加工米が使用される。米の
種類としては、粳米、もち米の両方が使用できる。ま
た、加工米としては、抗アレルギー米、低蛋白米(例え
ば低グリテリン米)、強化米(例えばγ−アミノ酪酸
米)などが挙げられる。米は破砕或いは粉末化せずにそ
のまま抽出に供するほうが、抽出物中への澱粉の混入等
が少なく望ましい。The rice used here is not particularly limited, and any of brown rice, polished rice, processed rice and the like can be used. Preferably, polished rice or processed rice is used. As the type of rice, both non-glutinous rice and glutinous rice can be used. Examples of the processed rice include antiallergic rice, low protein rice (for example, low glycerin rice), and enriched rice (for example, γ-aminobutyric acid rice). It is preferable that the rice is directly extracted without being crushed or powdered, because the amount of starch mixed into the extract is small.
【0008】抽出に用いる溶媒としては、水;メタノー
ル,エタノール、プロパノールなどの低級アルコール
類;エチレングリコール、プロピレングリコール、1,
3−ブチレングリコール、グリセリンなどの多価アルコ
ール類;酢酸エチル、酢酸ブチル、プロピオン酸メチル
などのエステル類;アセトン、メチルエチルケトンなど
のケトン類;エチルエーテル、イソプロピルエーテルな
どのエーテル類;n−ヘキサン、トルエン、クロロホル
ムなどの炭化水素系溶媒などがあり、それらはpH調整
なしで、もしくは酸又はアルカリでpH調整を行なった
上使用される。それらのうちでも、水又は水と低級アル
コール類との混液もしくは水と多価アルコール類との混
液の使用が好ましく、特にそれらを、水酸化ナトリウ
ム、水酸化カリウム、炭酸ナトリウムなどのアルカリを
用いて、pH7.5〜14、特にpH9〜12の範囲に
調整したアルカリ性水性媒体の使用が最も好ましい。The solvent used for the extraction is water; lower alcohols such as methanol, ethanol and propanol; ethylene glycol, propylene glycol,
Polyhydric alcohols such as 3-butylene glycol and glycerin; esters such as ethyl acetate, butyl acetate and methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; n-hexane and toluene And hydrocarbon solvents such as chloroform, which are used without pH adjustment or after pH adjustment with an acid or alkali. Among them, it is preferable to use water or a mixed solution of water and lower alcohols or a mixed solution of water and polyhydric alcohols, and particularly to use them with an alkali such as sodium hydroxide, potassium hydroxide, and sodium carbonate. The use of an alkaline aqueous medium adjusted to a pH of 7.5 to 14, especially pH 9 to 12 is most preferred.
【0009】抽出条件は、用いる米の種類、粒度さらに
は抽出溶媒等によっても異なるが、一般には4〜40℃
で6時間〜7日間の範囲であり、上記のアルカリ性水性
媒体を用いる場合であれば、4〜30℃で12〜36時
間が好適である。The extraction conditions vary depending on the type and particle size of the rice to be used, the extraction solvent and the like.
And the range is 6 hours to 7 days. When the above-mentioned alkaline aqueous medium is used, the temperature is preferably 4 to 30 ° C. and 12 to 36 hours.
【0010】ここに得られる米抽出物の加水分解処理
は、酸、アルカリもしくは酵素を用いて行なわれるが、
なかでも酵素による分解が、生成物の品質の均一性、工
程管理の容易性等の観点から好ましい。酸加水分解の場
合は、酸として塩酸、硫酸などを用い、抽出物溶液のp
Hを通常5以下、特に4以下とした上、60〜90℃で
1〜6時間加熱処理することによって行なわれる。ま
た、アルカリ加水分解の場合は、苛性ソーダ、苛性カ
リ、炭酸ソーダなどを用いて抽出物溶液のpHを9〜1
3に調整し、60〜90℃で1〜6時間加熱処理を行な
うのが一般的である。[0010] The hydrolysis treatment of the rice extract obtained here is carried out using an acid, an alkali or an enzyme.
Above all, decomposition by an enzyme is preferred from the viewpoint of uniformity of the quality of the product, ease of process control, and the like. In the case of acid hydrolysis, hydrochloric acid, sulfuric acid, or the like is used as an acid, and p of the extract solution is used.
H is usually adjusted to 5 or less, particularly 4 or less, and then heat-treated at 60 to 90 ° C. for 1 to 6 hours. In the case of alkaline hydrolysis, the pH of the extract solution is adjusted to 9 to 1 using caustic soda, caustic potash, sodium carbonate, or the like.
In general, the heat treatment is performed at 60 to 90 ° C. for 1 to 6 hours.
【0011】酵素による加水分解の場合、用いる酵素と
しては、アクチナーゼ類;ペプシンなどのペプシン類;
トリプシンなどのトリプシン類;パパイン、キモパパイ
ンなどのパパイン類;グリシルグリシンペプチダーゼ、
カルボキシペプチダーゼ、アミノペプチダーゼなどのペ
プチダーゼ類或いはブロメラインなどがあり、これらは
通常2種以上が併用される。酵素を組み合わせ用いる場
合、アクチナーゼとペプシン又はトリプシンとの組み合
わせが最も好ましい。In the case of hydrolysis by an enzyme, the enzymes used include actinases; pepsins such as pepsin;
Trypsins such as trypsin; papains such as papain and chymopapain; glycylglycine peptidase;
There are peptidases such as carboxypeptidase and aminopeptidase or bromelain, and these are usually used in combination of two or more. When enzymes are used in combination, the combination of actinase and pepsin or trypsin is most preferred.
【0012】それら酵素による加水分解処理は、米抽出
物(固形分)100重量部に対して、酵素を通常0.0
1〜10重量部、好ましくは0.05〜2.0重量部用
い、使用した酵素の至適pH及び至適温度付近の条件で
1〜24時間反応させることによって行なわれる。[0012] In the hydrolysis treatment with these enzymes, the enzyme is usually added to 100 parts by weight of rice extract (solid content) at 0.0
The reaction is carried out by using 1 to 10 parts by weight, preferably 0.05 to 2.0 parts by weight, for 1 to 24 hours under conditions near the optimum pH and the optimum temperature of the enzyme used.
【0013】ここに得られる米抽出物の加水分解物溶液
は、一般にはpHを4〜8に調整した上、そのままもし
くは減圧濃縮等により適宜の濃度として使用する。又場
合によっては、スプレードライ法、凍結乾燥法など常法
に従って粉末化して使用してもよい。The obtained rice extract hydrolyzate solution is generally adjusted to a pH of 4 to 8, and then used as it is or at an appropriate concentration by concentration under reduced pressure or the like. In some cases, the powder may be used after being pulverized according to a conventional method such as a spray drying method or a freeze drying method.
【0014】本発明の海産顕花植物抽出物の調製に用い
る海産顕花植物としては、例えばアマモ、コアマモ、ス
ガモ、エビアマモ、ウミヒルモ、マツバウミジグサ、ボ
ウバアマモ、リュウキュウスガモ、ベニアマモ、リュウ
キュウアマモ、ウミショウブなどが挙げられる。それら
のうちでも、アマモ、コアマモ、スガモ、ウミヒルモ、
ウミショウブ、特にアマモ或いはコアマモの使用が、本
発明の効果発現上好ましい。The marine flowering plants used for preparing the marine flowering plant extract of the present invention include, for example, eelgrass, koagumo, sugamo, shrimp eel, sea urchin, pine bamboo fever, boba eelgrass, ryukyuusugamo, veneer, ryukyuamamo, sea urchin, etc. Is mentioned. Among them, eelgrass, eelgrass, suga, sea hirumi,
The use of sea urchin, especially eelgrass or eelgrass, is preferred from the standpoint of achieving the effects of the present invention.
【0015】海産顕花植物の抽出物の調製は、一般に全
草を用い、これを水洗、乾燥後細切して、適宜の溶媒中
に浸漬することによって行なわれる。ここで抽出溶媒と
しては、水;メタノール,エタノール、プロパノールな
どの低級アルコール類;エチレングリコール、プロピレ
ングリコール、1,3−ブチレングリコール、グリセリ
ンなどの多価アルコール類;酢酸エチル、酢酸ブチル、
プロピオン酸メチルなどのエステル類;アセトン、メチ
ルエチルケトンなどのケトン類;エチルエーテル、イソ
プロピルエーテルなどのエーテル類;n−ヘキサン、ト
ルエン、クロロホルムなどの炭化水素系溶媒などがあ
り、それらのうちでも、特に水又は水と低級アルコール
類との混液もしくは水と多価アルコール類との混液の使
用が好ましい。Preparation of an extract of a marine flowering plant is generally carried out by using whole plants, washing them with water, drying, shredding them, and immersing them in an appropriate solvent. Examples of the extraction solvent include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; ethyl acetate, butyl acetate;
Esters such as methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene, and chloroform; Alternatively, it is preferable to use a mixed solution of water and lower alcohols or a mixed solution of water and polyhydric alcohols.
【0016】抽出温度、時間は、海産顕花植物の種類、
細切度、使用する溶媒等によっても異なるが、一般には
40〜90℃で1〜24時間、特に60〜80℃で2〜
5時間抽出を行なうのがよい。ここに得られる海産顕花
植物の抽出物溶液は、通常pHを4〜8に調整した上、
そのままもしくは減圧濃縮等により適宜の濃度として使
用される。また場合によっては、スプレードライ法、凍
結乾燥法など常法に従って粉末化して使用してもよい。The extraction temperature and time depend on the type of marine flowering plant,
Although the degree of shredding varies depending on the solvent used, etc., it is generally 40 to 90 ° C for 1 to 24 hours, particularly 60 to 80 ° C for
It is preferable to perform the extraction for 5 hours. The extract of the marine flowering plant obtained here is usually adjusted to pH 4 to 8,
It is used as it is or as an appropriate concentration by concentration under reduced pressure. In some cases, the powder may be used in the form of powder according to a conventional method such as a spray drying method and a freeze drying method.
【0017】本発明で用いるいま一つの成分であるアス
コルビン酸及びその誘導体(以下、アスコルビン酸類と
いう)としては、アスコルビン酸;L−アスコルビン酸
−2−リン酸エステル塩、L−アスコルビン酸−2−硫
酸エステル塩などのアスコルビン酸エステル塩類(塩は
ナトリウム塩、マグネシウム塩など)、L−アスコルビ
ン酸−2−グルコシド(2−O−α−D−グルコピラノ
シル−L−アスコルビン酸)、L−アスコルビン酸−5
−グルコシド(5−O−α−D−グルコピラノシル−L
−アスコルビン酸)などのアスコルビン酸配糖体類等が
あり、それらのうちでも特にL−アスコルビン酸−2−
グルコシドが好ましく用いられる。Ascorbic acid and its derivatives (hereinafter referred to as ascorbic acids) as another component used in the present invention include ascorbic acid; L-ascorbic acid-2-phosphate ester salt, L-ascorbic acid-2-phosphate. Ascorbic acid ester salts such as sulfates (sodium salts, magnesium salts and the like), L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid- 5
-Glucoside (5-O-α-D-glucopyranosyl-L
-Ascorbic acid) and the like, and among them, L-ascorbic acid-2-
Glucosides are preferably used.
【0018】本発明の皮膚外用剤は、以上の三種の成分
を組み合わせ配合してなるものであるが、それら成分の
配合比は、固形分比で、米抽出物の加水分解物100重
量部に対して、海産顕花植物抽出物が一般に10〜50
0重量部、好ましくは20〜300重量部、またアスコ
ルビン酸類が一般に500〜20000重量部、好まし
くは1000〜10000重量部の範囲である。また、
海産顕花植物抽出物とアスコルビン酸類の使用比は、上
記の範囲内で、固形分重量比として1:10〜1:20
0、特に1:20〜1:100とすることが好ましい。The external preparation for skin of the present invention is obtained by combining and mixing the above three components. The mixing ratio of these components is 100 parts by weight of the hydrolyzate of rice extract in terms of solid content. In contrast, marine flowering plant extracts are generally 10-50
0 parts by weight, preferably 20 to 300 parts by weight, and ascorbic acids generally range from 500 to 20,000 parts by weight, preferably from 1,000 to 10,000 parts by weight. Also,
The usage ratio between the marine flowering plant extract and the ascorbic acids is within the above range, and the solid content ratio is 1:10 to 1:20.
It is preferably 0, especially 1:20 to 1: 100.
【0019】本発明の皮膚外用剤中に於ける米抽出物加
水分解物、海産顕花植物抽出物及びアスコルビン酸類の
固形分配合量は、上記の配合比の範囲で、米抽出物加水
分解物の場合、一般に0.01〜1.0重量%、好まし
くは0.03〜0.15重量%、海産顕花植物抽出物の
場合、一般に0.005〜0.5重量%、好ましくは
0.01〜0.1重量%、またアスコルビン酸の場合、
一般に0.1〜10重量%、好ましくは1.0〜5.0
重量%の範囲である。The hydrolyzate of the rice extract, the marine flowering plant extract and the solid content of ascorbic acids in the skin preparation for external use of the present invention are as follows. In the case of a marine flowering plant extract, it is generally 0.005 to 0.5% by weight, preferably 0.1 to 1.0% by weight, preferably 0.03 to 0.15% by weight. 01-0.1% by weight, and in the case of ascorbic acid,
Generally 0.1 to 10% by weight, preferably 1.0 to 5.0%.
% By weight.
【0020】本発明の皮膚外用剤は、化粧料、医薬部外
品、医薬のいずれとしても使用可能であり、またその剤
型としては、例えばクリーム、乳液、ローション、軟
膏、パク剤、ハップ剤など用途、適用対象等に応じて適
宜のものが採用できる。The external preparation for skin of the present invention can be used as any of cosmetics, quasi-drugs and medicaments, and its dosage form is, for example, cream, milky lotion, lotion, ointment, paq, haptic For example, an appropriate one can be adopted according to the use, the application target, and the like.
【0021】本発明の皮膚外用剤には、必須成分の米抽
出物加水分解物、海産顕花植物抽出物及びアスコルビン
酸類のほかに、通常皮膚外用剤に用いられる成分、例え
ば油性成分、界面活性剤、保湿剤、増粘剤、防腐殺菌
剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香料等
が必要に応じて適宜配合される。The external preparation for skin of the present invention includes, in addition to the essential components, hydrolyzate of rice extract, extract of marine flowering plant and ascorbic acid, components usually used in external preparation for skin, such as oily component and surfactant. An agent, a humectant, a thickener, an antiseptic, a powder component, an ultraviolet absorber, an antioxidant, a pigment, a fragrance, and the like are appropriately compounded as necessary.
【0022】ここで、油性成分としては、例えばオリー
ブ油、ホホバ油、ヒマシ油、大豆油、ヤシ油、パーム
油、カカオ油などの植物由来の油脂類;ミンク油、ター
トル油などの動物由来の油脂類;ミツロウ、カルナウバ
ロウ、ラノリンなどのロウ類;流動パラフィン、ワセリ
ン、パラフィンワックス、スクワランなどの炭化水素
類;ミリスチン酸、パルミチン酸、ステアリン酸、オレ
イン酸、イソステアリン酸などの脂肪酸類;ラウリルア
ルコール、セタノール、ステアリルアルコールなどの高
級アルコール類;ミリスチン酸イソプロピル、パルミチ
ン酸イソプロピル、オレイン酸ブチル、2−エチルヘキ
シルグリセライドなどの合成エステル類及び合成トリグ
リセライド類等が挙げられる。The oily component includes, for example, plant-derived fats and oils such as olive oil, jojoba oil, castor oil, soybean oil, coconut oil, palm oil and cocoa oil; and animal-derived fats and oils such as mink oil and turtle oil. Waxes such as beeswax, carnauba wax and lanolin; hydrocarbons such as liquid paraffin, vaseline, paraffin wax and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid; lauryl alcohol, cetanol And higher esters such as stearyl alcohol; synthetic esters such as isopropyl myristate, isopropyl palmitate, butyl oleate, and 2-ethylhexyl glyceride; and synthetic triglycerides.
【0023】界面活性剤としては、例えばポリオキシエ
チレンアルキルエーテル、ポリオキシエチレン脂肪酸エ
ステル、ポリオキシエチレンソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸
エステル、ポリオキシエチレングリセリン脂肪酸エステ
ル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチ
レンソルビトール脂肪酸エステルなどの非イオン界面活
性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンス
ルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸
塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシ
エチレンアルキルフェニルエーテル硫酸塩、ポリオキシ
エチレンアルキルエーテル燐酸塩、α−スルホン化脂肪
酸アルキルエステル塩、ポリオキシエチレンアルキルフ
ェニルエーテル燐酸塩などのアニオン界面活性剤;第四
級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリ
アルキルベンジルアンモニウム塩、アルキルピリジニウ
ム塩、2−アルキル−1−アルキル−1−ヒドロキシエ
チルイミダゾリニウム塩、N,N−ジアルキルモルフォ
ルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩な
どのカチオン界面活性剤;N,N−ジメチル−N−アル
キル−N−カルボキシメチルアンモニオベタイン、N,
N,N−トリアルキル−N−アルキレンアンモニオカル
ボキシベタイン、N−アシルアミドプロピル−N′,
N′−ジメチル−N′−β−ヒドロキシプロピルアンモ
ニオスルホベタインなどの両性界面活性剤等が挙げられ
る。Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, and polyoxyethylene cured castor. Non-ionic surfactants such as oils and polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkyl benzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ethers Sulfate, polyoxyethylene alkyl ether phosphate, α-sulfonated fatty acid alkyl ester salt, polyoxyethylene alkyl phenyl ether phosphate Quaternary ammonium salts, primary to tertiary fatty amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts Cationic surfactants such as N, N, N-dialkylmorphonium salt and polyethylenepolyamine fatty acid amide salt; N, N-dimethyl-N-alkyl-N-carboxymethylammonio betaine;
N, N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N ',
And amphoteric surfactants such as N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine.
【0024】保湿剤としては、例えばグリセリン、プロ
ピレングリコール、ジプロピレングリコール、1,3−
ブチレングリコール、ポリエチレングリコール、ソルビ
トール、キシリトール、ピロリドンカルボンナトリウム
等があり、さらに糖類、ヒアルロン酸、乳酸、尿素、高
級脂肪酸オクチルドデシル、各種アミノ酸及びそれらの
誘導体が挙げられる。Examples of the humectant include glycerin, propylene glycol, dipropylene glycol, 1,3-
Examples include butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and further include saccharides, hyaluronic acid, lactic acid, urea, higher fatty acid octyldodecyl, various amino acids, and derivatives thereof.
【0025】増粘剤としては、例えばカラギーナン、ア
ルギン酸、ペクチン、ローカストビーンガムなどの多糖
類;キサンタンガム、トラガカントガム、グアーガムな
どのガム類;カルボキシメチルセルロース、ヒドロキシ
エチルセルロースなどのセルロース誘導体;ポリビニル
アルコール、ポリビニルピロリドン、カルボキシビニル
ポリマー、アクリル酸・メタクリル酸共重合体などの合
成高分子類;ヒアルロン酸及びその誘導体等が挙げられ
る。Examples of the thickener include polysaccharides such as carrageenan, alginic acid, pectin, and locust bean gum; gums such as xanthan gum, tragacanth gum and guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; polyvinyl alcohol, polyvinyl pyrrolidone; Synthetic polymers such as carboxyvinyl polymer and acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives;
【0026】防腐殺菌剤としては、例えば尿素;パラオ
キシ安息香酸メチル、パラオキシ安息香酸エチル、パラ
オキシ安息香酸プロピル、パラオキシ安息香酸ブチルな
どのパラオキシ安息香酸エステル類;フェノキシエタノ
ール、ジクロロフェン、ヘキサクロロフェン、塩酸クロ
ルヘキシジン、塩化ベンザルコニウム、サリチル酸、エ
タノール、ウンデシレン酸、フェノール類、ジャマール
(イミダゾディニールウレア)等がある。Examples of the preservative disinfectant include urea; paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate and butyl paraoxybenzoate; phenoxyethanol, dichlorophen, hexachlorophen, chlorhexidine hydrochloride, Examples include benzalkonium chloride, salicylic acid, ethanol, undecylenic acid, phenols, and jamal (imidazodinyl urea).
【0027】粉体成分としては、例えばセリサイト、酸
化チタン、タルク、カオリン、ベントナイト、酸化亜
鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコ
ニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパ
ウダー等がある。Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder and the like.
【0028】紫外線吸収剤としては、例えばパラアミノ
安息香酸エチル、パラジメチルアミノ安息香酸エチルヘ
キシル、サリチル酸アミル及びその誘導体、パラメトキ
シ桂皮酸エチルヘキシル、桂皮酸オクチル、2,4−ジ
ヒドロキシベンゾフェノン、2−ヒドロキシ−4−メト
キシベンゾフェノン−5−スルホン酸塩、2−(2−ヒ
ドロキシ−5−メチルフェニル)ベンゾトリアゾール、
ウロカニン酸、ウロカニン酸エチル等がある。Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, ethylhexyl paramethoxycinnamate, octyl cinnamate, 2,4-dihydroxybenzophenone, 2-hydroxy-4- Methoxybenzophenone-5-sulfonate, 2- (2-hydroxy-5-methylphenyl) benzotriazole,
There are urocanic acid, ethyl urocanate and the like.
【0029】抗酸化剤としては、例えばブチルヒドロキ
シアニソール、ブチルヒドロキシトルエン、没食子酸プ
ロピル、ビタミンE及びその誘導体等がある。又、その
他の成分として、レシチン類、シルク関連物質等を配合
することもできる。Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof. Further, as other components, lecithins, silk-related substances and the like can be blended.
【0030】本発明の皮膚外用剤には、本発明の組み合
わせ成分の有効性を損なわない範囲で、さらに他の生理
活性成分を配合してもよい。かかるものとしては、例え
ばコウジ酸、アルブチン、エラグ酸、レゾルシノール誘
導体(例えば4−n−ブチルレゾルシノール、4−イソ
アミルレゾルシノール等)、ソウハクヒ抽出液、ユキノ
シタ抽出液、米糠抽出物、2,5−ジヒドロキシ安息香
酸誘導体(例えば2,5−ジアセトキシ安息香酸等)な
どの美白成分;胎盤抽出物、コラーゲン、ニコチン酸及
びその誘導体(例えばニコチン酸アミド、ニコチン酸ベ
ンジル等)、ビタミンE及びその誘導体(例えばビタミ
ンEニコチネート、ビタミンEリノレート等)、α−ヒ
ドロキシ酸類(例えば乳酸、クエン酸、α−ヒドロキシ
オクタン酸等)、ジイソプロピルアミンジクロロアセテ
ート、γ−アミノ−β−ヒドロキシ酪酸などの皮膚老化
防止・肌荒れ改善成分;ゲンチアナエキスなどの生薬抽
出エキス等がある。The external preparation for skin of the present invention may further contain other physiologically active ingredients as long as the effectiveness of the combination component of the present invention is not impaired. Such substances include, for example, kojic acid, arbutin, ellagic acid, resorcinol derivatives (for example, 4-n-butyl resorcinol, 4-isoamyl resorcinol, etc.), soybean sap extract, saxifrage extract, rice bran extract, 2,5-dihydroxybenzoate Whitening ingredients such as acid derivatives (eg, 2,5-diacetoxybenzoic acid); placental extracts, collagen, nicotinic acid and its derivatives (eg, nicotinamide, benzyl nicotinate, etc.), vitamin E and its derivatives (eg, vitamin E) Nicotine, vitamin E linoleate, etc.), α-hydroxy acids (eg, lactic acid, citric acid, α-hydroxyoctanoic acid, etc.), diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, etc .; Gentian extract There is a drug extract, or the like.
【0031】次に、製造例、実施例(処方例)及び試験
例によって本発明をさらに具体的に説明するが、本発明
はそれらに限定されるものではない。なお、以下に於い
て、部はすべて重量部を意味する。Next, the present invention will be described more specifically with reference to Production Examples, Examples (formulation examples) and Test Examples, but the invention is not limited thereto. In the following, all parts mean parts by weight.
【0032】製造例1 米抽出物加水分解物溶液の調製
(1) 精白米100gを、0.25規定水酸化ナトリウム水溶
液400mlに、緩やかな攪拌下、室温で24時間浸漬
した。次に、不溶物をろ過で除き、ろ液をアクチナー
ゼ、ペプシン及びトリプシンで順次酵素処理した。酵素
処理は、酵素を各々5mg使用し、各酵素の至適pHに
於いて、夫々40℃に2時間保持することによって行な
った。ここに得られた酵素処理液をろ過して、淡黄色透
明の米抽出物加水分解物溶液270mlを得た(固形分
含量:1.5重量%)。Production Example 1 Preparation of Rice Extract Hydrolyzate Solution (1) 100 g of polished rice was immersed in 400 ml of a 0.25 N aqueous sodium hydroxide solution at room temperature for 24 hours with gentle stirring. Next, insoluble materials were removed by filtration, and the filtrate was subjected to enzyme treatment with actinase, pepsin and trypsin in this order. The enzymatic treatment was carried out by using 5 mg of each enzyme and maintaining each at the optimum pH of each enzyme at 40 ° C. for 2 hours. The obtained enzyme-treated solution was filtered to obtain 270 ml of a pale yellow and transparent rice extract hydrolyzate solution (solid content: 1.5% by weight).
【0033】製造例2 米抽出物加水分解物溶液の調製
(2) 酵素として、ペプシンに代えてパパインを用いるほかは
製造例1と同様にして、米抽出物加水分解物溶液250
mlを得た(固形分含量:1.5重量%)。Preparation Example 2 Preparation of Rice Extract Hydrolyzate Solution (2) A rice extract hydrolyzate solution 250 was prepared in the same manner as in Preparation Example 1 except that papain was used instead of pepsin as an enzyme.
ml (solid content: 1.5% by weight).
【0034】製造例3 米抽出物加水分解物溶液の調製
(3) 精白米100gを、0.25規定水酸化ナトリウム水溶
液400mlに、緩やかな攪拌下、室温で24時間浸漬
した。次に、不溶物をろ過で除き、ろ液を2規定水酸化
ナトリウム水溶液でpH10に調整した後、80℃に2
時間保持した。ここに得られた処理液をろ過して、淡黄
色透明の米抽出物加水分解物溶液250mlを得た(固
形分含量:1.4重量%)。Production Example 3 Preparation of Rice Extract Hydrolyzate Solution (3) 100 g of polished rice was immersed in 400 ml of 0.25 N aqueous sodium hydroxide at room temperature for 24 hours with gentle stirring. Next, the insoluble matter was removed by filtration, and the filtrate was adjusted to pH 10 with a 2N aqueous sodium hydroxide solution.
Hold for hours. The treatment liquid obtained here was filtered to obtain 250 ml of a pale yellow transparent rice extract hydrolyzate solution (solid content: 1.4% by weight).
【0035】製造例4 海産顕花植物抽出物溶液の調製
(1) アマモの全草を水洗して異物を除いた後天日で乾燥し、
約30mmに細切した。アマモの全草を水洗して異物を
除いた後天日で乾燥し、約30mmに細切した。この細
切物20gを水400mlに浸漬し、80℃で2時間抽
出した。この抽出液をろ過精製して、淡緑褐色の抽出物
溶液250gを得た(固形分含量:0.75重量%)。Production Example 4 Preparation of Marine Flowering Plant Extract Solution (1) The whole grass of eelgrass was washed with water to remove foreign substances, and then dried in the sun.
The pieces were cut into about 30 mm. The whole grass of the eelgrass was washed with water to remove foreign substances, dried in the sun, and cut into about 30 mm. 20 g of the cut pieces were immersed in 400 ml of water and extracted at 80 ° C. for 2 hours. This extract was filtered and purified to obtain 250 g of a pale green-brown extract solution (solid content: 0.75% by weight).
【0036】製造例5 海産顕花植物抽出物溶液の調製
(2) アマモに代えてコアマモを用いるほかは製造例4と同様
にして、淡緑褐色の抽出物溶液240gを得た(固形分
含量:0.75重量%)。Preparation Example 5 Preparation of Marine Flowering Plant Extract Solution (2) 240 g of a pale green-brown extract solution was obtained in the same manner as in Preparation Example 4 except that the eelgrass was used in place of the eelgrass (solid content). : 0.75% by weight).
【0037】 実施例1 クリーム [A成分] 部 流動パラフィン 5.0 ヘキサラン(株)テクノーブル製、トリオクタン酸グリセリル) 4.0 パラフィン 5.0 グリセリルモノステアレート 2.0 ポリオキシエチレン(20)ソルビタンモノステアレート 6.0 ブチルパラベン 0.1 [B成分] 製造例1の米抽出物加水分解物溶液 5.0 製造例4の海産顕花植物抽出物溶液 5.0 L−アスコルビン酸−2−グルコシド 2.0 グリセリン 5.0 カルボキシメチルモノステアレート 0.1 メチルパラベン 0.1 モイストン・C(株)テクノーブル製、NMF成分) 1.0 精製水 全量が100部となる量 [C成分] 香料 適量 上記のA成分とB成分をそれぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成
分を加えてさらに攪拌混合してクリームを調製した。Example 1 Cream [Component A] Part Liquid Paraffin 5.0 Hexalan Co., Ltd. Technoble Co., Ltd., glyceryl trioctanoate) 4.0 Paraffin 5.0 Glyceryl monostearate 2.0 Polyoxyethylene (20) sorbitan Monostearate 6.0 Butylparaben 0.1 [Component B] Rice extract hydrolyzate solution of Production Example 1 5.0 Marine flowering plant extract solution of Production Example 4 5.0 L-ascorbic acid-2- Glucoside 2.0 Glycerin 5.0 Carboxymethyl monostearate 0.1 Methyl paraben 0.1 Moiston C (manufactured by Technoble Co., Ltd., NMF component) 1.0 Purified water Amount that the total amount becomes 100 parts [Component C] Fragrance Appropriate amounts The above components A and B were each heated to 80 ° C. or higher, and then stirred and mixed. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare a cream.
【0038】 実施例2 乳液 [A成分] 部 流動パラフィン 6.0 ヘキサラン 4.0 ホホバ油 1.0 ポリオキシエチレン(20)ソルビタンモノステアレート 2.0 大豆レシチン 1.5 メチルパラベン 0.15 エチルパラベン 0.03 [B成分] 製造例1の米抽出物加水分解物溶液 5.0 製造例5の海産顕花植物抽出物溶液 5.0 L−アスコルビン酸−2−グルコシド 2.0 グリセリン 3.0 1,3−ブチレングリコール 2.0 カルボキシメチルセルロース 0.3 ヒアルロン酸ナトリウム 0.01 精製水 全量が100部となる量 [C成分] 香料 適量 上記のA成分とB成分をそれぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成
分を加えてさらに攪拌混合して乳液を調製した。Example 2 Emulsion [Component A] Part Liquid Paraffin 6.0 Hexalane 4.0 Jojoba Oil 1.0 Polyoxyethylene (20) Sorbitan Monostearate 2.0 Soybean Lecithin 1.5 Methylparaben 0.15 Ethylparaben 0.03 [Component B] Hydrolyzate solution of rice extract in Production Example 1 5.0 Solution of marine flowering plant extract in Production Example 5.0 5.0 L-ascorbic acid-2-glucoside 2.0 Glycerin 3.0 1,3-butylene glycol 2.0 carboxymethylcellulose 0.3 Sodium hyaluronate 0.01 Purified water Amount to make the total amount 100 parts [Component C] Perfume Appropriate amount The above components A and B were each heated to 80 ° C. or higher. Thereafter, the mixture was stirred and mixed. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare an emulsion.
【0039】 実施例3 ローション [成分] 部 製造例2の米抽出物加水分解物溶液 2.0 製造例4の海産顕花植物抽出物溶液 10.0 L−アスコルビン酸−2−グルコシド 2.0 エタノール 10.0 グリセリン 3.0 1,3−ブチレングリコール 2.0 メチルパラベン 0.2 クエン酸 0.1 クエン酸ナトリウム 0.3 カルボキシビニルポリマー 0.1 香料 適量 精製水 全量が100部となる量 上記の成分を混合してローションを調製した。Example 3 Lotion [Ingredients] Part Rice Extract Hydrolyzate Solution of Production Example 2 2.0 Marine Flowering Plant Extract Solution of Production Example 4 10.0 L-Ascorbic acid-2-glucoside 2.0 Ethanol 10.0 Glycerin 3.0 1,3-butylene glycol 2.0 Methyl paraben 0.2 Citric acid 0.1 Sodium citrate 0.3 Carboxyvinyl polymer 0.1 Perfume Appropriate amount Purified water The amount that the total amount becomes 100 parts Was mixed to prepare a lotion.
【0040】 実施例4 パック [成分] 部 ポリビニルアルコール 15.0 ヒドロキシメチルセルロース 5.0 プロピレングリコール 5.0 エタノール 10.0 メチルパラベン 0.2 実施例3の米抽出物加水分解物溶液 2.0 実施例4の海産顕花植物抽出物溶液 10.0 L−アスコルビン酸−2−グルコシド 2.0 香料 適量 精製水 全量が100部となる量 上記の成分を混合してパックを調製した。Example 4 Pack [Components] Part Polyvinyl alcohol 15.0 Hydroxymethylcellulose 5.0 Propylene glycol 5.0 Ethanol 10.0 Methylparaben 0.2 Rice extract hydrolyzate solution of Example 3 2.0 Example Marine flowering plant extract solution of No. 4 10.0 L-Ascorbic acid-2-glucoside 2.0 Perfume Appropriate amount Purified water An amount that gives a total amount of 100 parts The above components were mixed to prepare a pack.
【0041】実施例5 クリーム 実施例1に於いて、L−アスコルビン酸−2−グルコシ
ドの代わりにL−アスコルビン酸−2−リン酸エステル
マグネシウム塩を用いるほかは実施例1と同様にしてク
リームを調製した。Example 5 Cream A cream was prepared in the same manner as in Example 1 except that magnesium L-ascorbic acid-2-phosphate was used in place of L-ascorbic acid-2-glucoside. Prepared.
【0042】実施例6 クリーム 実施例1に於いて、L−アスコルビン酸−2−グルコシ
ドの代わりにL−アスコルビン酸−2−硫酸エステルナ
トリウム塩を用いるほかは実施例1と同様にしてクリー
ムを調製した。Example 6 Cream A cream was prepared in the same manner as in Example 1 except that sodium L-ascorbic acid-2-sulfate was used in place of L-ascorbic acid-2-glucoside. did.
【0043】試験例1 日焼け肌回復試験 紫外線照射によりダメージを受けた皮膚に対する本発明
の皮膚外用剤の機能回復促進効果を、色素沈着の状況、
角質層の重層剥離の程度及び皮膚表面の水分量の各経時
変化に基づいて評価した。Test Example 1 Sunburn Recovery Test The effect of the external preparation for skin of the present invention on the recovery of the function of the skin damaged by ultraviolet irradiation was evaluated by examining the condition of pigmentation,
The evaluation was based on the degree of exfoliation of the stratum corneum and the change over time in the amount of water on the skin surface.
【0044】[試験方法]3cm角の穴2個を10mm
の間隔で穿設したアルミ板を、被験者5名(男性、年齢
25〜52歳)のそれぞれの上腕部に貼付し、これに別
途求めた1MED相当の紫外線を照射し(東芝製UV−
BランプFL−20SE使用)、その24時間後に同部
位に重ねてさらに1MEDの紫外線照射を行なった。2
回目の紫外線照射の直後から1日2回(朝夕)4週間に
わたって、照射部2箇所のそれぞれに、表1に示す組成
からなる本発明のローション又は比較ローションを塗布
し、皮膚の色素沈着状況、角質層の重層剥離の程度及び
皮膚表面の水分量を、紫外線照射直後(1回目及び2回
目)、2回目の紫外線照射後3、6、10、14、21
及び28日目に、それぞれ以下に述べる方法により測定
し、評価した。[Test Method] Two 3 cm square holes were inserted into 10 mm
Are attached to the upper arms of five subjects (male, ages 25 to 52), and irradiated with ultraviolet rays equivalent to 1 MED separately obtained (UV-Toshiba-made).
B lamp FL-20SE was used), and 24 hours later, another 1 MED ultraviolet irradiation was performed on the same portion. 2
Immediately after the second UV irradiation, twice a day (morning and evening) for 4 weeks, the lotion of the present invention or the comparative lotion having the composition shown in Table 1 was applied to each of the two irradiated portions, and the pigmentation status of the skin was determined. The degree of exfoliation of the stratum corneum and the amount of water on the skin surface were measured immediately after UV irradiation (first and second times), 3, 6, 10, 14, 21 after the second UV irradiation.
On the 28th and 28th days, measurement and evaluation were performed by the methods described below, respectively.
【0045】[0045]
【表1】 [Table 1]
【0046】(1)色素沈着状況 コンピューターにより日焼け肌に近い色調(赤茶系)で
5段階の濃度の色標準紙を作成し、日焼け部位の色調と
照合して最も近い色調番号を選択し評点とした。この場
合、最も濃い赤茶系を5とし、肌色に近い淡い赤茶系を
1とした。(1) Pigmentation Situation A color standard paper of five levels of density was prepared by a computer with a color tone (reddish brown) close to tanned skin, and the color tone number of the closest color tone was selected by comparing it with the color tone of the tanned part. And In this case, the darkest reddish brown color was set to 5, and the pale reddish brown color close to flesh color was set to 1.
【0047】(2)角質層の重層剥離の程度 透明両面テープを、支持体(スライドグラス)に貼付し
て紫外線照射/ローション塗布部位に強く押し付けた後
剥がし、これを染色液(0.25%ブリリアントグリー
ン含有0.5%ゲンチアナバイオレット溶液)に15分
間浸漬し、流水で染色液を洗い流した後風乾した。次
に、皮膚から両面テープに転写、染色された角質層を、
顕微鏡により観察した。即ち、顕微鏡の視野10箇所を
無作為にとり、視野中の角質層全体のうち重なり合って
剥離している部分(重層剥離)の占める割合を、下記の
基準に基づいて目視にて評価した。結果は10視野の平
均値で示した。(2) Degree of exfoliation of stratum corneum A transparent double-sided tape was adhered to a support (slide glass), strongly pressed against a site to which ultraviolet light was applied / lotion applied, and then peeled off. It was immersed in brilliant green-containing 0.5% gentian violet solution for 15 minutes, washed with running water to remove the staining solution, and then air-dried. Next, the horny layer transferred from the skin to the double-sided tape and stained,
Observed under a microscope. That is, 10 places in the visual field of the microscope were randomly taken, and the proportion of the overlapping and peeling parts (layer peeling) in the entire stratum corneum in the visual field was visually evaluated based on the following criteria. The results were shown as the average value of 10 visual fields.
【0048】[評価基準] 5 : ほとんど見当たらない 4 : 僅かに見られる 3 : 多少見られる 2 : かなり見られる 1 : 非常に多く見られる[Evaluation Criteria] 5: Almost not found 4: Slightly seen 3: Somewhat seen 2: Fairly seen 1: Very often seen
【0049】(3)皮膚表面の水分量 紫外線照射/ローション塗布部位2箇所とそれに近接し
た正常部位について、インピーダンスメーターにより測
定を行なった。(3) Moisture Content on the Skin Surface Two places of ultraviolet irradiation / lotion application and a normal part adjacent thereto were measured with an impedance meter.
【0050】[結果]試験結果を表2(色素沈着の状
態)、表3(角質層の重層剥離の程度)及び表4(皮膚
表面の水分量)に示した。[Results] The test results are shown in Table 2 (state of pigmentation), Table 3 (degree of exfoliation of stratum corneum), and Table 4 (moisture amount on skin surface).
【0051】[0051]
【表2】 [Table 2]
【0052】[0052]
【表3】 [Table 3]
【0053】[0053]
【表4】 [Table 4]
【0054】表2の結果から、紫外線の照射により、い
ずれのローションの塗布部位も徐々に色素沈着が進み、
6日目にピークに達するが、本発明のローションを塗布
した部位の場合は、比較ローション塗布部位よりも色素
沈着の度合が少なく、またその後速やかに正常部位に近
い色調に戻ることが判る。From the results shown in Table 2, the pigmentation gradually progressed at the application site of any lotion by the irradiation of ultraviolet rays.
It reaches a peak on the sixth day, and it can be seen that the site where the lotion of the present invention is applied has a lower degree of pigmentation than the site where the comparative lotion is applied, and then returns to a color tone close to the normal site immediately thereafter.
【0055】また、表3に示す通り、本発明の有効成分
を含まない比較ローションの塗布部位には、紫外線照射
後3〜14日目に強度の重層剥離が認められたのに対
し、本発明のローションの塗布部位では、同時期に重層
剥離が観察されたものの、比較ローションに比べて遥か
に軽度であり、全期間を通じて、重層剥離の程度は正常
部位に近いものであった。また、本発明のローション塗
布部位は、紫外線照射によるダメージからの回復が早
い。Further, as shown in Table 3, the application of the comparative lotion containing no active ingredient of the present invention showed strong multilayer peeling 3 to 14 days after the irradiation with ultraviolet rays, whereas the comparative lotion did not contain the active ingredient of the present invention. In the lotion-applied site, the delamination was observed at the same time, but was much lighter than the comparative lotion, and the degree of delamination was close to the normal portion throughout the entire period. In addition, the lotion application site of the present invention recovers quickly from damage due to ultraviolet irradiation.
【0056】さらに、表4の結果から、紫外線照射によ
り皮膚表面の水分量は低下するものの、本発明のローシ
ョン塗布部位では、比較ローション塗布部位に比べて、
低下の度合が顕著に少なく、かつ正常部位への回復が早
いことが判る。Further, from the results shown in Table 4, although the moisture content on the skin surface is reduced by the irradiation of the ultraviolet rays, the lotion-applied portion of the present invention has a smaller amount than the comparative lotion-applied portion.
It can be seen that the degree of the decrease is remarkably small and the recovery to the normal site is quick.
【0057】日焼けした皮膚は色素沈着が起こり、かさ
つきや表皮の剥がれを生ずるなど正常皮膚に比べて不健
全な状態を呈するが、上記の試験結果から明らかな通
り、本発明の皮膚外用剤によれば、日焼けによるそれら
の皮膚損傷の程度が軽減されると共に、正常な皮膚への
回復も促進される。The tanned skin shows an unhealthy state as compared with normal skin, such as pigmentation, which causes bulkiness and peeling of the epidermis. As is clear from the above test results, the tanned skin preparation of the present invention has According to this, the degree of their skin damage due to sunburn is reduced, and the restoration to normal skin is promoted.
【0058】[0058]
【発明の効果】米抽出物加水分解物と海産顕花植物抽出
物とアスコルビン酸類とを組み合わせ配合してなる本発
明の皮膚外用剤は、日焼け等に基づく皮膚の色素沈着、
角質層の剥離など皮膚の老化乃至損傷現象に対して、す
ぐれた防御並びに症状改善作用を有し、これを皮膚に適
用した時、日焼け等による皮膚のダメージが軽減される
と共に、皮膚は早期に健全かつ健常な状態に回復する。The external preparation for skin of the present invention comprising a combination of a hydrolyzate of rice extract, a marine flowering plant extract and ascorbic acids is effective for skin pigmentation based on sunburn and the like.
It has an excellent defense and ameliorating effect on skin aging or damage phenomena such as exfoliation of the stratum corneum, and when applied to the skin, the skin damage due to sunburn etc. is reduced and the skin Recover to a healthy and healthy state.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 N 35/78 35/78 W A61P 17/16 A61P 17/16 (72)発明者 大澤 豊 大阪市西区北堀江1丁目6番8号共栄化学 工業株式会社内 (72)発明者 小椋 貴子 大阪市西区北堀江1丁目6番8号共栄化学 工業株式会社内 Fターム(参考) 4C083 AA111 AA112 AA122 AC012 AC022 AC102 AC122 AC302 AC352 AC422 AC442 AC482 AD092 AD112 AD282 AD332 AD572 AD661 AD662 CC04 CC05 CC07 DD12 DD23 DD31 EE06 EE12 EE16 4C088 AB71 AB74 AC01 AC04 BA08 CA25 MA07 MA08 MA16 MA28 MA32 MA63 ZA89 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/00 A61K 7/00 N 35/78 35/78 W A61P 17/16 A61P 17/16 (72) Inventor Yutaka Osawa 1-6-8 Kitahorie, Nishi-ku, Osaka-shi Kyoei Chemical Industry Co., Ltd. (72) Inventor Takako Ogura 1-6-8 Kitahorie, Nishi-ku, Osaka City F-term in Kyoei Chemical Industry Co., Ltd. (Reference) 4C083 AA111 AA112 AA122 AC012 AC022 AC102 AC122 AC302 AC352 AC422 AC442 AC482 AD092 AD112 AD282 AD332 AD572 AD661 AD662 CC04 CC05 CC07 DD12 DD23 DD31 EE06 EE12 EE16 4C088 AB71 AB74 AC01 AC04 BA08 CA25 MA07 MA08 MA16 MA28 MA32 MA63 ZA89
Claims (6)
抽出物とアスコルビン酸及び/又はその誘導体とを配合
してなる皮膚外用剤。An external preparation for skin comprising a hydrolyzate of a rice extract, an extract of a marine flowering plant, and ascorbic acid and / or a derivative thereof.
性媒体抽出物を2種以上の蛋白分解酵素で処理して得ら
れたものである請求項1に記載の皮膚外用剤。2. The external preparation for skin according to claim 1, wherein the hydrolyzate of the rice extract is obtained by treating an alkaline medium extract of rice with two or more proteases.
と、(b)ペプシン類、トリプシン類、パパイン類、ペ
プチダーゼ類及びブロメラインからなる群から選ばれた
1種又は2種以上との組合せからなる請求項2に記載の
皮膚外用剤。3. The proteolytic enzyme comprises a combination of (a) an actinase and (b) one or more selected from the group consisting of pepsins, trypsins, papains, peptidases and bromelain. The external preparation for skin according to claim 2.
の抽出物である請求項1に記載の皮膚外用剤。4. The external preparation for skin according to claim 1, wherein the extract of the marine flowering plant is an extract of an eelgrass plant.
る請求項4に記載の皮膚外用剤。5. The external preparation for skin according to claim 4, wherein the eelgrass plant is eelgrass or eelgrass.
D−グルコピラノシル−L−アスコルビン酸である請求
項1に記載の皮膚外用剤。6. The ascorbic acid derivative is 2-O-α-
The external preparation for skin according to claim 1, which is D-glucopyranosyl-L-ascorbic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000229995A JP2002003362A (en) | 2000-06-22 | 2000-06-22 | Skin care preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000229995A JP2002003362A (en) | 2000-06-22 | 2000-06-22 | Skin care preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002003362A true JP2002003362A (en) | 2002-01-09 |
Family
ID=18723019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000229995A Pending JP2002003362A (en) | 2000-06-22 | 2000-06-22 | Skin care preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002003362A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004026766A (en) * | 2002-06-27 | 2004-01-29 | Kyoei Kagaku Kogyo Kk | Skin care preparation for external use |
| JP2006298808A (en) * | 2005-04-19 | 2006-11-02 | Hayashibara Biochem Lab Inc | Pain stimulant |
| JP2006306816A (en) * | 2005-04-28 | 2006-11-09 | Kyoei Kagaku Kogyo Kk | A cosmetic comprising a testosterone-5α-reductase inhibitor and a testosterone-5α-reductase inhibitor. |
| JP2010538622A (en) * | 2007-09-14 | 2010-12-16 | ウルサファルム アルツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Recombinant preparation of selected bromelain fragments |
| JP2019182777A (en) * | 2018-04-09 | 2019-10-24 | 頂宏生物科技股▲分▼有限公司 | Hydrolysate of water extract of java syzygium jambos and production method thereof and use thereof |
-
2000
- 2000-06-22 JP JP2000229995A patent/JP2002003362A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004026766A (en) * | 2002-06-27 | 2004-01-29 | Kyoei Kagaku Kogyo Kk | Skin care preparation for external use |
| JP2006298808A (en) * | 2005-04-19 | 2006-11-02 | Hayashibara Biochem Lab Inc | Pain stimulant |
| JP2006306816A (en) * | 2005-04-28 | 2006-11-09 | Kyoei Kagaku Kogyo Kk | A cosmetic comprising a testosterone-5α-reductase inhibitor and a testosterone-5α-reductase inhibitor. |
| JP2010538622A (en) * | 2007-09-14 | 2010-12-16 | ウルサファルム アルツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Recombinant preparation of selected bromelain fragments |
| JP2019182777A (en) * | 2018-04-09 | 2019-10-24 | 頂宏生物科技股▲分▼有限公司 | Hydrolysate of water extract of java syzygium jambos and production method thereof and use thereof |
| JP7090886B2 (en) | 2018-04-09 | 2022-06-27 | 頂宏生物科技股▲分▼有限公司 | Hydrolyzate of watery rose apple extract and method for producing the hydrolyzate and use of the hydrolyzate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3576200B2 (en) | Whitening cosmetics | |
| JP6266857B2 (en) | Cosmetics | |
| JP6689024B2 (en) | External skin preparation | |
| JPH08325130A (en) | Cosmetic | |
| JP3936808B2 (en) | How to reduce skin irritation | |
| JP6510744B2 (en) | Cosmetics | |
| JP2002003362A (en) | Skin care preparation | |
| JP2005145878A (en) | Cosmetic and cosmetic compounding agent | |
| JP4424561B2 (en) | Whitening cosmetics | |
| JP5177827B2 (en) | Topical skin preparation | |
| JP4592911B2 (en) | Cosmetics | |
| JP2012201615A (en) | Elastase activity inhibitor | |
| JP2011195539A (en) | Elastase activity inhibitor | |
| JP2002128632A (en) | Cosmetic | |
| JP4824933B2 (en) | Cosmetics | |
| JP4573545B2 (en) | Cosmetics | |
| JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
| JP2016102098A (en) | Hair cosmetics | |
| JP4445658B2 (en) | Cosmetics | |
| JP2015151388A (en) | cosmetic | |
| JP2004026766A (en) | Skin care preparation for external use | |
| JP2019014669A (en) | External composition for skin | |
| JP3818998B2 (en) | Whitening cosmetics | |
| JP2000044459A (en) | Skin preparation for external use | |
| JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070606 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090625 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090721 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090918 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100301 |